Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Janux Therapeutics (JANX) Prepaid Assets: 2020-2024

Historic Prepaid Assets for Janux Therapeutics (JANX) over the last 5 years, with Dec 2024 value amounting to $8.5 million.

  • Janux Therapeutics' Prepaid Assets rose 9.69% to $9.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.1 million, marking a year-over-year increase of 9.69%. This contributed to the annual value of $8.5 million for FY2024, which is 62.92% up from last year.
  • Janux Therapeutics' Prepaid Assets amounted to $8.5 million in FY2024, which was up 62.92% from $5.2 million recorded in FY2023.
  • In the past 5 years, Janux Therapeutics' Prepaid Assets ranged from a high of $8.5 million in FY2024 and a low of $249,000 during FY2020.
  • Over the past 3 years, Janux Therapeutics' median Prepaid Assets value was $5.4 million (recorded in 2022), while the average stood at $6.4 million.
  • As far as peak fluctuations go, Janux Therapeutics' Prepaid Assets spiked by 724.90% in 2021, and later declined by 3.87% in 2023.
  • Janux Therapeutics' Prepaid Assets (Yearly) stood at $249,000 in 2020, then skyrocketed by 724.90% to $2.1 million in 2021, then skyrocketed by 164.02% to $5.4 million in 2022, then decreased by 3.87% to $5.2 million in 2023, then spiked by 62.92% to $8.5 million in 2024.